Comparative Pharmacology
Head-to-head clinical analysis: CONSTULOSE versus NULYTELY FLAVORED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CONSTULOSE versus NULYTELY FLAVORED.
CONSTULOSE vs NULYTELY-FLAVORED
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids, leading to an osmotic effect that draws water into the bowel, thereby softening stools and increasing bowel motility. In hepatic encephalopathy, lactulose acidifies the colonic environment, promoting the conversion of ammonia (NH3) to ammonium (NH4+), which is trapped and excreted in feces.
NULYTELY-FLAVORED is an osmotic laxative containing polyethylene glycol (PEG) 3350 and electrolytes. It induces diarrhea by retaining water in the colon through osmotic action, thereby cleansing the bowel.
10-20 g (15-30 mL) orally once daily, increased to 30-45 g (45-60 mL) if needed; or 30-45 g (45-60 mL) orally every 6-8 hours for hepatic encephalopathy.
Adult dose: 4 liters of reconstituted solution orally as a single dose, or 240 mL (8 oz) every 10 minutes until 4 liters are consumed, approximately 1-1.5 hours before colonoscopy.
None Documented
None Documented
Not applicable due to minimal systemic absorption; local action in colon. In cases of systemic absorption, half-life is not clinically relevant.
Not applicable; PEG 3350 is not significantly absorbed and does not exhibit a terminal elimination half-life in the systemic circulation. Clinical effect is due to local osmotic action in the gut.
Primarily fecal (unchanged); minimal systemic absorption (<3%), thus negligible renal excretion.
Primarily fecal elimination as unabsorbed PEG 3350; minimal systemic absorption (<0.06%). Renal excretion of absorbed fraction is negligible.
Category C
Category C
Osmotic Laxative
Osmotic Laxative